Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Non-Current Deffered Revenue (2017 - 2025)

Historic Non-Current Deffered Revenue for Ascendis Pharma A (ASND) over the last 9 years, with Q4 2025 value amounting to $1.3 million.

  • Ascendis Pharma A's Non-Current Deffered Revenue fell 7553.16% to $1.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.3 million, marking a year-over-year decrease of 7553.16%. This contributed to the annual value of $1.3 million for FY2025, which is 7624.72% down from last year.
  • Per Ascendis Pharma A's latest filing, its Non-Current Deffered Revenue stood at $1.3 million for Q4 2025, which was down 7553.16% from $4.9 million recorded in Q3 2025.
  • In the past 5 years, Ascendis Pharma A's Non-Current Deffered Revenue ranged from a high of $14.5 million in Q4 2022 and a low of -$7.6 million during Q4 2023
  • Over the past 5 years, Ascendis Pharma A's median Non-Current Deffered Revenue value was $2.7 million (recorded in 2022), while the average stood at $2.9 million.
  • Per our database at Business Quant, Ascendis Pharma A's Non-Current Deffered Revenue skyrocketed by 3114024.28% in 2022 and then crashed by 31319.36% in 2025.
  • Over the past 5 years, Ascendis Pharma A's Non-Current Deffered Revenue (Quarter) stood at $3.4 million in 2021, then skyrocketed by 327.66% to $14.5 million in 2022, then crashed by 152.53% to -$7.6 million in 2023, then surged by 170.14% to $5.3 million in 2024, then crashed by 75.53% to $1.3 million in 2025.
  • Its Non-Current Deffered Revenue was $1.3 million in Q4 2025, compared to $4.9 million in Q3 2025 and $2.0 million in Q2 2025.